Načítá se...
Exosome therapeutics for COVID‐19 and respiratory viruses
Respiratory viral diseases are a leading cause of mortality in humans. They have proven to drive pandemic risk due to their complex transmission factors and viral evolution. However, the slow production of effective antiviral drugs and vaccines allows for outbreaks of these diseases, emphasizing a c...
Uloženo v:
| Vydáno v: | View (Beijing) |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995024/ https://ncbi.nlm.nih.gov/pubmed/34766162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/VIW.20200186 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|